{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:47:28Z","timestamp":1771480048598,"version":"3.50.1"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Direction G\u00e9n\u00e9rale de l\u2019Armement (DGA)","award":["Biomedef PDH-2-NRBC-5-B-4120"],"award-info":[{"award-number":["Biomedef PDH-2-NRBC-5-B-4120"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The vaccinia virus (VACV) was previously used as a vaccine for smallpox eradication. Nowadays, recombinant VACVs are developed as vaccine platforms for infectious disease prevention and cancer treatment. The conventional method for genome editing of the VACV is based on homologous recombination, which is poorly efficient. Recently, the use of CRISPR\/Cas9 technology was shown to greatly improve the speed and efficiency of the production of recombinant VACV expressing a heterologous gene. However, the ability to rapidly recover viruses bearing single nucleotide substitutions is still challenging. Notwithstanding, ongoing studies on the VACV and its interaction with the host cell could benefit from viral gene targeted mutagenesis. Here, we present a modified version of the CRISPR\/Cas9 system for the rapid selection of mutant VACV carrying point mutations. For this purpose, we introduced a silent mutation into the donor gene (which will replace the wildtype gene) that serves a double function: it is located in the PAM (NGG) sequence, which is essential for Cas9 cleavage, and it alters a restriction site. This silent mutation, once introduced into the VACV genome, allows for rapid selection and screening of mutant viruses carrying a mutation of interest in the targeted gene. As a proof of concept, we produced several recombinant VACVs, with mutations in the E9L gene, upon which, phenotypic analysis was performed.<\/jats:p>","DOI":"10.3390\/v14071559","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:19:21Z","timestamp":1658189961000},"page":"1559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficient Method for Generating Point Mutations in the Vaccinia Virus Genome Using CRISPR\/Cas9"],"prefix":"10.3390","volume":"14","author":[{"given":"Laetitia","family":"Boutin","sequence":"first","affiliation":[{"name":"Virology Unit, Institut de Recherche Biom\u00e9dicale des Arm\u00e9es, 91220 Br\u00e9tigny-sur-Orge, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Mosca","sequence":"additional","affiliation":[{"name":"Virology Unit, Institut de Recherche Biom\u00e9dicale des Arm\u00e9es, 91220 Br\u00e9tigny-sur-Orge, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3909-9688","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Iseni","sequence":"additional","affiliation":[{"name":"Virology Unit, Institut de Recherche Biom\u00e9dicale des Arm\u00e9es, 91220 Br\u00e9tigny-sur-Orge, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1080\/21645515.2020.1840887","article-title":"Vaccinia virus-based vector against infectious diseases and tumors","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_2","first-page":"7","article-title":"Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates","volume":"7","author":"Chiuppesi","year":"2022","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified Vaccinia Virus Ankara","volume":"97","author":"Volz","year":"2017","journal-title":"Adv. Virus Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4161\/hv.9693","article-title":"Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV\/AIDS","volume":"5","author":"Esteban","year":"2009","journal-title":"Hum. Vaccines"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40425-018-0495-7","article-title":"Vaccinia virus-mediated cancer immunotherapy: Cancer vaccines and oncolytics","volume":"7","author":"Guo","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2019.03.005","article-title":"The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism","volume":"14","author":"Foloppe","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","article-title":"Infectious poxvirus vectors have capacity for at least 25000 base pairs of foreign DNA","volume":"25","author":"Smith","year":"1983","journal-title":"Gene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/viro.2000.0686","article-title":"In vitro concatemer formation catalyzed by vaccinia virus DNA polymerase","volume":"278","author":"Willer","year":"2000","journal-title":"Virology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cpps.33","article-title":"Generation of Recombinant Vaccinia Viruses","volume":"89","author":"Wyatt","year":"2017","journal-title":"Curr. Protoc. Protein Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1128\/JVI.00339-15","article-title":"Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system","volume":"89","author":"Yuan","year":"2015","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/mtm.2015.35","article-title":"A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9","volume":"2","author":"Yuan","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_13","first-page":"e54171","article-title":"A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors","volume":"116","author":"Yuan","year":"2016","journal-title":"J. Vis. Exp."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s42003-020-01374-6","article-title":"Rapid poxvirus engineering using CRISPR\/Cas9 as a selection tool","volume":"3","author":"Gowripalan","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: A fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhin.2004.01.012","article-title":"Rapid inactivation of vaccinia virus in suspension and dried on surfaces","volume":"57","author":"Ferrier","year":"2004","journal-title":"J. Hosp. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1128\/JVI.00605-06","article-title":"Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulence in Mice","volume":"80","author":"Andrei","year":"2006","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1743-422X-5-58","article-title":"Isolation and characterization of cidofovir resistant vaccinia viruses","volume":"5","author":"Becker","year":"2008","journal-title":"Virol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-017-01542-z","article-title":"The vaccinia virus DNA polymerase structure provides insights into the mode of processivity factor binding","volume":"8","author":"Tarbouriech","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"167009","DOI":"10.1016\/j.jmb.2021.167009","article-title":"Solution Structure of the C-terminal Domain of A20, the Missing Brick for the Characterization of the Interface between Vaccinia Virus DNA Polymerase and its Processivity Factor","volume":"433","author":"Bersch","year":"2021","journal-title":"J. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yuan, M., Webb, E., Lemoine, N.R., and Wang, Y. (2016). CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses. Viruses, 8.","DOI":"10.3390\/v8030072"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"166896","DOI":"10.1016\/j.jmb.2021.166896","article-title":"MAVERICC: Marker-free Vaccinia Virus Engineering of Recombinants through in vitro CRISPR\/Cas9 Cleavage","volume":"433","author":"Laudermilch","year":"2021","journal-title":"J. Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1074\/jbc.M511239200","article-title":"Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase","volume":"281","author":"Stanitsa","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/JVI.01533-12","article-title":"Low-resolution structure of vaccinia virus DNA replication machinery","volume":"87","author":"Gabel","year":"2013","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.virusres.2017.01.027","article-title":"The vaccinia virus DNA polymerase and its processivity factor","volume":"234","author":"Czarnecki","year":"2017","journal-title":"Virus Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00239-001-0078-x","article-title":"Evolution of DNA polymerase families: Evidences for multiple gene exchange between cellular and viral proteins","volume":"54","author":"Forterre","year":"2002","journal-title":"J. Mol. Evol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1016\/S0021-9258(18)36019-8","article-title":"Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus","volume":"254","author":"Challberg","year":"1979","journal-title":"J. Biol. Chem."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/7\/1559\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:53:03Z","timestamp":1760140383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/7\/1559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["v14071559"],"URL":"https:\/\/doi.org\/10.3390\/v14071559","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]}}}